Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metastatic Thyroid Carcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00118248
What this trial is testing

Tanespimycin in Treating Patients With Inoperable Locoregionally Advanced or Metastatic Thyroid Cancer

Who this might be right for
Recurrent Thyroid CancerStage IV Follicular Thyroid CancerStage IV Papillary Thyroid Cancer+1 more
National Cancer Institute (NCI) 41
Early research (Phase 1)Study completedNCT05410821
What this trial is testing

Evaluation of 177Lu-DOTA-EB-FAPI in Patients With Metastatic Radioactive Iodine Refractory Thyroid Cancer

Who this might be right for
Refractory Thyroid Gland CarcinomaRefractory Thyroid Gland Papillary CarcinomaRefractory Thyroid Gland Follicular Carcinoma+1 more
The First Affiliated Hospital of Xiamen University 12
Not applicableLooking for participantsNCT06623578
What this trial is testing

Comparative Study of Transaxillary Robotic Thyroidectomy With MRND Versus Conventional Open Surgery in N1b PTC

Who this might be right for
Papillary Thyroid CarcinomaLymphatic Metastasis
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 876
Early research (Phase 1)Active Not RecruitingNCT04877613
What this trial is testing

GFRα4 CAR T Cells in MTC Patients

Who this might be right for
Metastatic Medullary Thyroid CancerRecurrent Thyroid Gland Medullary Carcinoma
University of Pennsylvania 9
Not applicableUnknownNCT04880798
What this trial is testing

Effect of Thyrotropin Level on Iodine Uptake in Metastatic Differentiated Thyroid Cancer

Who this might be right for
Differentiated Thyroid Cancer
Peking Union Medical College Hospital 10
Testing effectiveness (Phase 2)Ended earlyNCT04161391
What this trial is testing

Study of TPX-0046, A RET/SRC Inhibitor in Adult Subjects With Advanced Solid Tumors Harboring RET Fusions or Mutations

Who this might be right for
Non Small Cell Lung CancerMedullary Thyroid CancerRET Gene Mutation+2 more
Turning Point Therapeutics, Inc. 41
Not applicableLooking for participantsNCT06405217
What this trial is testing

Recombinant Human Thyroid Stimulating Hormone for Radioiodine 131I Treatment

Who this might be right for
DTC - Differentiated Thyroid CancerThyroid Stimulating; Hormone, CRadiotherapy; Complications
Nanjing First Hospital, Nanjing Medical University 30
Not applicableStudy completedNCT02109250
What this trial is testing

CAPRELSA® REGISTRY: a Belgian Registry to Evaluate the Use of Vandetanib (Caprelsa®) in Current Clinical Practice

Who this might be right for
Metastatic Medullary Thyroid Cancer
Genzyme, a Sanofi Company 10
Testing effectiveness (Phase 2)Study completedNCT00654238
What this trial is testing

Phase II Trial of Sorafenib (Nexavar) in Patients With Advanced Thyroid Cancer

Who this might be right for
Metastatic Differentiated Thyroid CancerMetastatic Poorly Differentiated Thyroid CancerMetastatic Anaplastic Thyroid Cancer+1 more
University of Pennsylvania 59
Testing effectiveness (Phase 2)Study completedNCT00510640
What this trial is testing

Thyroid Cancer and Sunitinib

Who this might be right for
CancerThyroid Carcinoma
University Hospital, Bordeaux 71
Early research (Phase 1)Study completedNCT00655655
What this trial is testing

Everolimus and Vatalanib in Treating Patients With Advanced Solid Tumors

Who this might be right for
GastrinomaGlucagonomaInsulinoma+17 more
Mayo Clinic 96
Not applicableStudy completedNCT07391514
What this trial is testing

Deep Learning-Based Intraoperative Dual-tracer Video Analysis of Sentinel Lymph Node Mapping for Metastasis Prediction in cN0 Papillary Thyroid Carcinoma

Who this might be right for
Papillary Thyroid Carcinoma
First Affiliated Hospital of Chongqing Medical University 131
Not applicableStudy completedNCT00428220
What this trial is testing

A Continuation Study Using Sunitinib Malate For Patients Leaving Treatment On A Previous Sunitinib Study.

Who this might be right for
Metastatic Breast CancerAdvanced Breast CancerMetastatic Castration Resistant Prostate Cancer+9 more
Pfizer 223
Testing effectiveness (Phase 2)Study completedNCT03072160
What this trial is testing

Pembrolizumab in Recurrent or Metastatic Medullary Thyroid Cancer

Who this might be right for
Medullary Thyroid Cancer (MTC)
National Cancer Institute (NCI) 17
Early research (Phase 1)Study completedNCT00470496
What this trial is testing

Photodynamic Therapy Using HPPH in Treating Patients Undergoing Surgery for Primary or Recurrent Head and Neck Cancer

Who this might be right for
Recurrent Adenoid Cystic Carcinoma of the Oral CavityRecurrent Basal Cell Carcinoma of the LipRecurrent Esthesioneuroblastoma of the Paranasal Sinus and Nasal Cavity+52 more
Roswell Park Cancer Institute 15
Early research (Phase 1)Study completedNCT00005842
What this trial is testing

Trastuzumab Plus R115777 in Treating Patients With Advanced or Metastatic Cancer

Who this might be right for
Cancer
National Cancer Institute (NCI) 24
Early research (Phase 1)Study completedNCT00004062
What this trial is testing

Azacitidine to Restore Thyroid Function in Patients With Persistent or Metastatic Thyroid Cancer

Who this might be right for
Head and Neck Cancer
Lucille P. Markey Cancer Center at University of Kentucky
Testing effectiveness (Phase 2)Study completedNCT00094055
What this trial is testing

Study of the Anti-angiogenesis Agent AG-013736 in Patients With Metastatic Thyroid Cancer

Who this might be right for
Thyroid Neoplasms
Pfizer 60
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06991738
What this trial is testing

177Lu-DOTA-EB-TATE in Adult Patients With Metastatic, Radioactive Iodine Non-Responsive Oncocytic (Hurthle-Cell) Thyroid Cancer

Who this might be right for
Thyroid Cancer
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 18
Testing effectiveness (Phase 2)UnknownNCT04619316
What this trial is testing

Enhancing Radioiodine Incorporation Into Radio Iodine Refractory Thyroid Cancers With MAPK Inhibition

Who this might be right for
Metastatic Thyroid Cancer
University Hospital, Essen 70
Next Page